Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.35
Price to sales ratio
0.45
Dividends per share
1.16
Dividend yield %
8.33

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2082
BHC
Bausch Health Companies Inc. Common Stock
4.76 USD-2.06%-2.06%-5.56%-25.74%1.78 B USD
2166
HROW
Harrow, Inc. - Common Stock
41.37 USD-1.05%-9.49%+5.08%+6.08%1.54 B USD
2268
PAHC
Phibro Animal Health Corporation - Class A Common Stock
33.04 USD+0.12%+0.70%+0.85%+7.73%1.34 B USD
2383
COLL
Collegium Pharmaceutical, Inc. - Common Stock
35.02 USD+0.57%-3.34%+1.42%-0.34%1.14 B USD

Frequently asked questions about Perrigo Company plc Ordinary Shares

What is the Perrigo Company plc Ordinary Shares stock price today?

The current price of Perrigo Company plc Ordinary Shares (PRGO) is 9.92. Over the past 24 hours, the stock has changed by -2.55%. Follow the PRGO chart for real-time price dynamics.

What is the stock ticker of Perrigo Company plc Ordinary Shares?

Perrigo Company plc Ordinary Shares trades under the ticker PRGO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Perrigo Company plc Ordinary Shares stock going up?

PRGO has changed by -11.43% over the last week, -7.38% over the last month, and -53.90% over the last year. Review the chart to see whether the current move is part of a broader trend.

Does Perrigo Company plc Ordinary Shares release financial reports?

Yes. You can track Perrigo Company plc Ordinary Shares financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What was Perrigo Company plc Ordinary Shares net income for the last quarter?

Perrigo Company plc Ordinary Shares reported net income of -398.6 M for the last quarter. The previous quarter showed -1.42 B, which means net income changed by +71.89%.

How many employees does Perrigo Company plc Ordinary Shares have?

As of the latest available data, Perrigo Company plc Ordinary Shares has 8 100 employees. Workforce size can provide additional context about the company's scale and operations.

What is Perrigo Company plc Ordinary Shares EBITDA?

Perrigo Company plc Ordinary Shares EBITDA is -289 M, and its EBITDA margin is -29.82%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Perrigo Company plc Ordinary Shares stock?

You can buy Perrigo Company plc Ordinary Shares (PRGO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Perrigo Company plc Ordinary Shares stock?

Investing in Perrigo Company plc Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PRGO chart and related analysis on metatrader.com as part of your research.

Perrigo Company plc Ordinary Shares

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park. Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value.

News